Altamira Therapeutics Ltd. Equity
Altamira Therapeutics Ltd. (CYTOF) had Equity of $4.07 million as of 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes
ifrs-full:Equity · last filed 2025-08-29
- 2023-12-31: Equity 6.46M CHF.
- 2023-06-30: Equity -1.82M CHF.
- 2022-12-31: Equity -8.31M CHF.
- 2022-06-30: Equity 6.74M CHF; Equity as first filed 7.68M CHF.
CHF
| Period end | Equity | Equity as first filed |
|---|---|---|
| 2023-12-31 | 6.46M CHF 20-F/A · filed 2024-04-22 | |
| 2023-06-30 | -1.82M CHF 6-K · filed 2023-09-12 | |
| 2022-12-31 | -8.31M CHF 20-F/A · filed 2024-04-22 | |
| 2022-06-30 | 6.74M CHF 6-K · filed 2023-09-12 | 7.68M CHF 6-K · filed 2022-11-30 |
| 2021-12-31 | 13.04M CHF 20-F/A · filed 2024-04-22 | 12.70M CHF 20-F · filed 2022-04-12 |
| 2021-06-30 | 20.09M CHF 6-K/A · filed 2023-08-21 | |
| 2020-12-31 | 16.77M CHF 20-F/A · filed 2024-04-22 | |
| 2020-06-30 | 4.48M CHF 6-K · filed 2021-09-08 | |
| 2019-12-31 | 6.04M CHF 20-F · filed 2023-05-16 | |
| 2019-06-30 | 8.95M CHF 6-K/A · filed 2020-09-17 | |
| 2018-12-31 | 3.65M CHF 20-F · filed 2022-04-12 | |
| 2018-06-30 | -3.55M CHF 6-K · filed 2019-08-15 | |
| 2017-12-31 | -2.16M CHF 20-F · filed 2021-03-31 | |
| 2016-12-31 | 14.14M CHF 20-F · filed 2020-04-16 | |
| 2015-12-31 | 44.74M CHF 20-F · filed 2019-03-14 | |
| 2014-12-31 | 53.28M CHF 20-F · filed 2018-03-22 |
USD
| Period end | Equity |
|---|---|
| 2025-06-30 | $4.07M 6-K · filed 2025-08-29 |
| 2024-12-31 | $6.57M 6-K · filed 2025-08-29 |
| 2024-06-30 | $6.32M 6-K · filed 2025-08-29 |
| 2023-12-31 | $7.68M 6-K · filed 2025-08-29 |
| 2023-06-30 | -$2.04M 6-K · filed 2024-09-24 |
| 2023-01-01 | -$8.99M 6-K · filed 2024-09-24 |
| 2022-12-31 | -$8.99M 20-F · filed 2025-04-30 |
| 2021-12-31 | $14.31M 20-F · filed 2025-04-30 |